Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Am J Otolaryngol ; 15(3): 190-2, 1994.
Article in English | MEDLINE | ID: mdl-8024106

ABSTRACT

PURPOSE: Because the incidence of nasopharyngeal carcinoma differs in various ethnic groups, the heterogeneous population of Jerusalem was selected for an epidemiologic study. MATERIALS AND METHODS: Data from 63 consecutive patients diagnosed with nasopharyngeal carcinoma were collected in a retrospective manner. Information regarding sex, age, ethnic origin, tobacco and alcohol consumption, chronic sinusitis, and immunoglobulin (Ig)G to Epstein-Barr virus capsid antigen was tabulated and was statistically analyzed by the z test. RESULTS: The results showed an increased incidence of disease in the Sephardi Jews, especially of Moroccan origin. The histologic type was 100% poorly differentiated squamous carcinoma, and was associated with a better prognosis than is usually seen in the literature. CONCLUSION: This study identified an ethnic-related pattern of nasopharyngeal carcinoma in Jerusalem, and found a 100% incidence of poorly differentiated squamous carcinoma, and a better survival rate than the literature suggests, which may be attributable to the histologic type.


Subject(s)
Carcinoma, Squamous Cell/epidemiology , Nasopharyngeal Neoplasms/epidemiology , Adolescent , Adult , Aged , Antibodies, Viral/blood , Capsid/immunology , Carcinoma, Squamous Cell/ethnology , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/therapy , Ethnicity , Female , Herpesvirus 4, Human/immunology , Humans , Incidence , Israel/epidemiology , Jews , Male , Middle Aged , Morocco/ethnology , Nasopharyngeal Neoplasms/ethnology , Nasopharyngeal Neoplasms/pathology , Nasopharyngeal Neoplasms/therapy , Neoplasm Staging , Retrospective Studies , Survival Rate
2.
Gematol Transfuziol ; 36(1): 21-3, 1991 Jan.
Article in Russian | MEDLINE | ID: mdl-2065940

ABSTRACT

Interstitial pneumonitis is one of the most serious complications in patients after bone marrow transplantation, and irradiation plays the main role in its etiology. A total of 44 patients with blood diseases were subjected to total-body irradiation before bone marrow transplantation. Chemotherapy, cyclophosphamide in a dose of 60 mg/kg/day, was conducted during two successive days. Group I patients (n-23) were subjected to irradiation in a total dose of 12 Gy used as 6 fractions of 2 Gy twice a day, during 3 successive days. Group II patients, after irradiation with 6 Gy, were protected with lung shields that inhibited 50% of irradiation thus reducing the irradiation dose in the area of the lung up to 9 Gy. Then the patients received a total dose of 6 Gy during two days. Radiation pneumonitis developed in 6 out of 23 patients, 3 of them died. No non-infectious complications of the lungs were observed in group II patients with partial protection of the lung tissue. The data obtained have evidenced that thoroughly developed radiotherapeutic program with a special attention to the prevention of excessive irradiation of the lung tissue can reduce incidence of radiation pneumonitis in patients after bone marrow transplantation.


Subject(s)
Bone Marrow Transplantation/methods , Leukemia/surgery , Lung/radiation effects , Pulmonary Fibrosis/prevention & control , Radiation Injuries/prevention & control , Radiation Protection/methods , Whole-Body Irradiation/adverse effects , Adolescent , Adult , Child , Humans , Middle Aged , Postoperative Care , Pulmonary Fibrosis/etiology , Radiation Injuries/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...